SYNERGY™

Everolimus-Eluting Platinum Chromium Coronary Stent System

Leading on Studying Short DAPT

Boston Scientific is committed to clinical science that meets what physicians encounter in their everyday practice, including the need for shortened DAPT. We are studying shortened DAPT with the SYNERGY Bioabsorbable Polymer (BP) Stent in various patient populations.

 

 

SENIOR*

 

1-month DAPT in stable elderly patients
6-month DAPT in ACS elderly patients

 

View the SENIOR Trial data  

1,200 Patients
SYNERGY BP-DES vs REBEL™ BMS

 

 

EVOLVE Short DAPT

 

3-month DAPT in HBR patients

 

 

View the EVOLVE Short DAPT
Trial data >
 

2,009 Patients
IDE Trial | SYNERGY BP-DES
 

 

IDEAL Left Main*

 
4-month DAPT in Left Main with SYNERGY BP-DES
12-month DAPT in Left Main with Xience™ PP-DES
818 Patients
Left Main PCI

 

 

ASET*

 
0-month DAPT in patients with chronic stable angina

200 Patients
SYNERGY BP-DES

 

 

POEM*

 
1-month DAPT in HBR patients
1,023 Patients
SYNERGY BP-DES

 

 

SYNIVUS-DAPT*

 
1-month DAPT in HBR patients
100 Patients
SYNERGY BP-DES
IVUS
 

 
Early Healing

Early Healing

Advanced design for optimal healing

Button
Clinical Outcomes

Clinical Outcomes

Outstanding evidence across trials

Button
Efficiency

Efficiency

How design impacts economic value

Button
 
 
Top